Ann Ital Chir4 Jul 2024
Aberrant hepatic artery is common in patients with hepatocellular carcinoma, with complex variations impacting treatment. A retrospective study of 1250 patients showed a high incidence of aberrant hepatic artery (21.3%), affecting operation duration and postoperative outcomes. Variations included aberrant left and right hepatic artery origins.…
Hepatobiliary Surg Nutr3 Jul 2024
Establishing preoperative chemotherapy (PCT) with FOLFIRINOX and gemcitabine/nab-paclitaxel enabled resectability in 61.2% of 139 patients with initially unresectable locally advanced pancreatic cancer. PCT did not increase perioperative mortality or morbidity, with 92.9% achieving R0 resection. Median postoperative survival was 31 months, highlighting the significant potential…
Hepatobiliary Surg Nutr3 Jul 2024
Laparoscopic surgery shows improved survival rates, less bleeding, shorter hospital stays, and lower complication rates compared to open surgery for gallbladder cancer. However, concerns remain due to factors like incidental cancer, heterogeneity, publication bias, and lymph node dissection. Subgroup analyses suggest ethnicity, sample size, and…
Int J Surg3 Jul 2024
Patients with hepatocellular carcinoma undergoing major hepatectomy had higher complication rates and shorter recurrence-free survival compared to those undergoing minor hepatectomy, regardless of propensity score matching. Major hepatectomy was identified as an independent predictor for HCC recurrence. Minor hepatectomy resulted in fewer postoperative complications and…
Surg Laparosc Endosc Percutan Tech2 Jul 2024
Primary suturing after microincision of the cystic duct confluence is safe and effective for treating CBD stones in patients with a normal CBD diameter. A retrospective study on 104 patients with gallstone complications showed no significant differences in perioperative outcomes between normal and dilated CBD…
Ann Surg Oncol30 Jun 2024
Larger tumor size and elevated serum chromogranin A levels are predictive of metastatic disease in patients with gastroenteropancreatic neuroendocrine tumors undergoing DOTATATE imaging. Patients with primary tumor size ≥2 cm, serum CGA level ≥150 ng/ml, and tumor grade g2 are at higher risk of metastases,…
BMC Surg30 Jun 2024
Preoperative biliary drainage method significantly impacts outcomes in patients with biliary tract and pancreatic cancer undergoing pancreaticoduodenectomy. Higher morbidity rates were observed with endoscopic biliary drainage methods compared to percutaneous drainage. Percutaneous drainage was associated with worse disease-free survival in biliary tract cancer but did…
J Gastrointest Surg30 Jun 2024
Patients with pancreatic neuroendocrine tumors face a 20% risk of disease recurrence or metastasis post-pancreatectomy, with prognostic factors like larger tumor size, high ki-67 index, perineural invasion, and node-positive disease significantly impacting disease-free survival. Non-functional tumors are more prevalent, with 2-year and 5-year disease-free survival…
Indian J Gastroenterol30 Jun 2024
Among cancers, carcinoma gallbladder presents a poor prognosis. A study developed a risk score based on key clinical and imaging factors to predict malignancy in patients with suspicious gallbladder lesions. The model demonstrated a sensitivity of 78% and specificity of 70.4%, aiding in early identification…
Surg Endosc29 Jun 2024
Minimally invasive liver surgery (MILS) has doubled in incidence from 2013 to 2022, now representing 25.2% of liver resections in France. Major liver resections, primary, and secondary malignant tumors show the highest annual increases. University hospitals and high-volume centers are leading the adoption of MILS.…